Fintel reports that on February 28, 2025, Craig-Hallum initiated coverage of MediWound (NasdaqGM:MDWD) with a Buy ...

Craig-Hallum initiated coverage of MediWound (MDWD) with a Buy rating and $39 price target As a part wound care and part biotech company, ...

Craig-Hallum lowered the firm’s price target on Airgain (AIRG) to $9 from $12 and keeps a Buy rating on the shares. The firm says the company ...

Arlo Technologies (NYSE:ARLO – Get Free Report) had its price target lifted by investment analysts at Craig Hallum from ...

As previously reported, Craig-Hallum analyst Albert Lowe initiated coverage of Eupraxia Pharmaceuticals (EPRX) with a Buy ...

Why Craig-Hallum Cut Its Rating on AXON After Axon’s shares surged 93% over the last year, Craig-Hallum believes that the shares’ risk-reward ratio is balanced. News Today's news ...

ACM Research (NASDAQ:ACMR – Get Free Report) was upgraded by equities researchers at Craig Hallum from a “hold” rating to a “buy” rating in a research note issued to investors on Wednesday, Ratings ...

Axon Enterprise ( AXON -11.73%) stock is moving lower in Thursday's trading. The company's share price was down 10.9% as of 12:30 p.m. ET. Meanwhile, the S&P 500 ( ^GSPC -0.79%) was down 0.7%, and the ...

As of February 19, 2025, the average one-year price target for MediWound is $29.58/share. The forecasts range from a low of $25.25 to a high of $37.80. The average price target represents an ...